<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04539899</url>
  </required_header>
  <id_info>
    <org_study_id>35RC20_8886_REAVIST</org_study_id>
    <nct_id>NCT04539899</nct_id>
  </id_info>
  <brief_title>Evaluation of the Influence of the Virtual Reality Helmet on Pain During IUD Insertion</brief_title>
  <acronym>REAVIST</acronym>
  <official_title>Evaluation of the Influence of the Virtual Reality Helmet on Pain During IUD Insertion : REAVIST</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Given the current lack of satisfactory options for the management of IUD insertion pain,&#xD;
      could the virtual reality headset be an innovative and effective tool? The objective is to&#xD;
      compare the pain experienced during IUD insertion between a group of women wearing a virtual&#xD;
      reality helmet and a group not wearing one.&#xD;
&#xD;
      Observational, prospective, randomized, open-label, monocentric study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 23, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS during IUD insertion</measure>
    <time_frame>20 minutes</time_frame>
    <description>The assessment criterion used is the written self-report numerical scale (NRS) from 0 to 10 (0 = no pain, 10 = extremely painful)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>IUD</condition>
  <arm_group>
    <arm_group_label>VR+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For patients in the experimental group, using the virtual reality helmet, the caregiver will position the helmet on the patient when she is placed on the gynecological examination table. He or she will make sure that the patient can see and hear the current sequence. The caregiver can then proceed with the different steps of the IUD insertion. Once the procedure is completed, the caregiver will indicate to the patient that she can remove the headphones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VR-</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>For patients in the control group, without a helmet, the course of the consultation will not be modified.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VR+</intervention_name>
    <description>Use of a virtual reality helmet during IUD insertion</description>
    <arm_group_label>VR+</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female adult&#xD;
&#xD;
          -  Who has benefited from contraceptive counseling&#xD;
&#xD;
          -  The choice of an IUD (hormonal or copper)&#xD;
&#xD;
          -  Having signed a written informed consent.&#xD;
&#xD;
          -  Affiliation to a social security scheme.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-existing dizzying sensations&#xD;
&#xD;
          -  Severe facial wounds&#xD;
&#xD;
          -  History of epilepsy&#xD;
&#xD;
          -  Persons of full age subject to legal protection (safeguard of justice, curatorship,&#xD;
             guardianship), persons deprived of liberty.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Method of female contraception</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vincent Lavoue, Pr</last_name>
    <phone>2.99.28.43.21</phone>
    <phone_ext>+33</phone_ext>
    <email>vincent.lavoue@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Laure Gervais, PhD</last_name>
    <phone>2.99.28.25.55</phone>
    <phone_ext>33</phone_ext>
    <email>marie-laure.gervais@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CÃ©line Bouhnik</last_name>
      <email>celine.bouhnik@etudiant.univ-rennes1.fr</email>
    </contact>
    <investigator>
      <last_name>Chloe Guicheteau</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

